ViCentra has developed an insulin pump for diabetes patients.
ViCentra has raised $13.0M in total funding. The most recent round was Series D. The last funding was announced in January 2026.
ViCentra's investors include Invest-NL, EQT Life Sciences, Innovation Industries, Inkef, Kreos Capital.
ViCentra is headquartered in Utrecht, The Netherlands.
ViCentra has developed an insulin pump for diabetes patients.
ViCentra is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ViCentra — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/vicentra. Accessed July 20, 2026.
VCBacked. (2026). ViCentra — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/vicentra
{{cite web |title=ViCentra — Funding & Investors |url=https://www.vcbacked.co/company/vicentra |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated